These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21508153)

  • 21. Resistant Mycobacterium bovis Bacillus Calmette-Guérin disease: implications for management of Bacillus Calmette-Guérin Disease in human immunodeficiency virus-infected children.
    Hesseling AC; Schaaf HS; Victor T; Beyers N; Marais BJ; Cotton MF; Wiid I; Gie RP; van Helden P; Warren RM
    Pediatr Infect Dis J; 2004 May; 23(5):476-9. PubMed ID: 15131480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rifampicin-resistant Mycobacterium bovis BCG strain isolated from an infant with NEMO mutation].
    Çavuşoğlu C; Edeer Karaca N; Azarsız E; Ulusoy E; Kütükçüler N
    Mikrobiyol Bul; 2015 Apr; 49(2):272-7. PubMed ID: 26167828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro drug susceptibility of Mycobacterium bovis BCG Connaught and Tokyo strains.
    Shimizu T; Yasumoto K; Tatano Y; Tomioka H; Sato K; Sano C; Kumon H; Monden K
    J Infect; 2010 Mar; 60(3):248-51. PubMed ID: 20074586
    [No Abstract]   [Full Text] [Related]  

  • 24. Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis?
    de Jong BC; Onipede A; Pym AS; Gagneux S; Aga RS; DeRiemer K; Small PM
    J Clin Microbiol; 2005 Jul; 43(7):3530-2. PubMed ID: 16000498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liver.
    Balazuc AM; Lagranderie M; Chavarot P; Pescher P; Roseeuw E; Schacht E; Domurado D; Marchal G
    Microbes Infect; 2005 Jun; 7(7-8):969-75. PubMed ID: 15994108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum.
    Piersimoni C; Mustazzolu A; Giannoni F; Bornigia S; Gherardi G; Fattorini L
    J Clin Microbiol; 2013 Jan; 51(1):291-4. PubMed ID: 23100351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of katG gene in resistant Mycobacterium tuberculosis.
    Jaber M; Rattan A; Kumar R
    J Clin Pathol; 1996 Nov; 49(11):945-7. PubMed ID: 8944618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation.
    Wang XD; Gu J; Wang T; Bi LJ; Zhang ZP; Cui ZQ; Wei HP; Deng JY; Zhang XE
    Mol Microbiol; 2011 Dec; 82(6):1375-91. PubMed ID: 22026918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Microbacterial resistance to antibiotic preparations].
    Savchenko PIu
    Mikrobiol Zh; 1970; 32(3):376-82. PubMed ID: 4996138
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis.
    Fujiwara M; Kawasaki M; Hariguchi N; Liu Y; Matsumoto M
    Tuberculosis (Edinb); 2018 Jan; 108():186-194. PubMed ID: 29523322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human bovine tuberculosis - remains in the differential.
    Bilal S; Iqbal M; Murphy P; Power J
    J Med Microbiol; 2010 Nov; 59(Pt 11):1379-1382. PubMed ID: 20688950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of disseminated Mycobacterium bovis infection in an AIDS patient.
    Albrecht H; Stellbrink HJ; Eggers C; Rüsch-Gerdes S; Greten H
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):226-9. PubMed ID: 7614965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of Arabino glycosyl triazoles as potential inhibitors of mycobacterial cell wall biosynthesis.
    Wilkinson BL; Long H; Sim E; Fairbanks AJ
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6265-7. PubMed ID: 18926698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory diagnosis of antibiotic resistant Mycobacterium bovis within 48 h: a qualitative change in the approach to mycobacterial diseases in AIDS patients.
    Espinosa de los Monteros LE; Gomez-Mampaso E; Cobo J; Guerrero A; Baquero F; Blazquez J
    AIDS; 1997 May; 11(6):827-8. PubMed ID: 9143622
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular basis of rifampin and isoniazid resistance in Mycobacterium bovis strains isolated in Sardinia, Italy.
    Sechi LA; Zanetti S; Sanguinetti M; Molicotti P; Romano L; Leori G; Delogu G; Boccia S; La Sorda M; Fadda G
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1645-8. PubMed ID: 11353606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the stability of drugs in biological media. 2. Relationship between the stability in culture media and anti-bacterial activity of some isoniazid derivatives.
    Kakemi K; Sezaki H; Iwamoto K; Sano Y
    Chem Pharm Bull (Tokyo); 1969 Aug; 17(8):1623-8. PubMed ID: 4981613
    [No Abstract]   [Full Text] [Related]  

  • 38. InbR, a TetR family regulator, binds with isoniazid and influences multidrug resistance in Mycobacterium bovis BCG.
    Yang M; Gao CH; Hu J; Zhao L; Huang Q; He ZG
    Sci Rep; 2015 Sep; 5():13969. PubMed ID: 26353937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of isoniazid complex with A-I apolipoprotein on activity of lysosomal enzymes in mice with tuberculous inflammation model].
    Sumenkova DV; Poliakov LM; Panin LE
    Eksp Klin Farmakol; 2012; 75(11):28-30. PubMed ID: 23323330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
    Ahmad Z; Tyagi S; Minkowsk A; Almeida D; Nuermberger EL; Peck KM; Welch JT; Baughn AS; Jacobs WR; Grosset JH
    Indian J Med Res; 2012 Nov; 136(5):808-14. PubMed ID: 23287128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.